Several emerging agents are attracting focus within the biomedical sector. Retatrutide, a dual GLP-1 and GIP receptor modulator, is demonstrating promise for obesity control. BPC-157, or Cor Peptide 157, is believed to https://ghk-cu299283.wikicorrespondence.com/7307901/retatrutide_bpc_157_ghk_cu_tb_500_a_deep_dive_into_emerging_compounds